Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis.

ABSTRACT:

Objective

To address the knowledge gap regarding medical care costs for advanced cancer patients, we compared costs for recurrent versus de novo stage IV breast, colorectal, and lung cancer patients.

Data sources/study setting

Virtual Data Warehouse (VDW) information from three Kaiser Permanente regions: Colorado, Northwest, and Washington.

Study design

We identified patients aged ≥21 with de novo or recurrent breast (n_de novo  = 352; n_recurrent  = 765), colorectal (n_{de novo}  = 1,072; n_recurrent  = 542), and lung (n_{de novo}  = 4,041; n_recurrent  = 340) cancers diagnosed 2000-2012. We estimated average total monthly and annual costs in the 12 months preceding, month of, and 12 months following the index d

SUBMITTER: Ritzwoller DP 

PROVIDER: S-EPMC6232408 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature